Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interface-guided phenotyping of coding variants in the transcription factor RUNX1.
Ozturk K, Panwala R, Sheen J, Ford K, Jayne N, Portell A, Zhang DE, Hutter S, Haferlach T, Ideker T, Mali P, Carter H. Ozturk K, et al. Among authors: haferlach t. Cell Rep. 2024 Jul 23;43(7):114436. doi: 10.1016/j.celrep.2024.114436. Epub 2024 Jul 4. Cell Rep. 2024. PMID: 38968069 Free PMC article.
Interface-guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS.
Ozturk K, Panwala R, Sheen J, Ford K, Payne N, Zhang DE, Hutter S, Haferlach T, Ideker T, Mali P, Carter H. Ozturk K, et al. Among authors: haferlach t. bioRxiv [Preprint]. 2023 Aug 4:2023.08.03.551876. doi: 10.1101/2023.08.03.551876. bioRxiv. 2023. Update in: Cell Rep. 2024 Jul 23;43(7):114436. doi: 10.1016/j.celrep.2024.114436 PMID: 37577681 Free PMC article. Updated. Preprint.
Relevance of blast counts for genetic subclassification in MDS.
Huber S, Haferlach T, Hutter S, Hoermann G, Kern W, Haferlach C. Huber S, et al. Among authors: haferlach t. Leukemia. 2024 Nov 27. doi: 10.1038/s41375-024-02484-4. Online ahead of print. Leukemia. 2024. PMID: 39604619 No abstract available.
A simple score for clonal cytopenias.
Haferlach T. Haferlach T. Blood. 2024 Nov 7;144(19):1981-1982. doi: 10.1182/blood.2024026076. Blood. 2024. PMID: 39509123 No abstract available.
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.
Sobas MA, Turki AT, Ramiro AV, Hernández-Sánchez A, Elicegui JM, González T, Melchor RA, Abáigar M, Tur L, Dall'Olio D, Sträng E, Tettero JM, Castellani G, Benner A, Döhner K, Thiede C, Metzeler KH, Haferlach T, Damm F, Ayala R, Martínez-López J, Mills KI, Sierra J, Lehmann S, Porta MGD, Mayer J, Reinhardt D, Medina RV, Schulze-Rath R, Barbus M, Hernández-Rivas JM, Huntly BJP, Ossenkoppele G, Döhner H, Bullinger L. Sobas MA, et al. Among authors: haferlach t. Haematologica. 2024 Nov 7. doi: 10.3324/haematol.2024.285805. Online ahead of print. Haematologica. 2024. PMID: 39506894 Free article.
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project.
Voso MT, Guarnera L, Lehmann S, Döhner K, Döhner H, Platzbecker U, Russell NH, Dillon RJ, Thomas I, Ossenkoppele GJ, Haferlach T, Vignetti M, La Sala E, Piciocchi A, Fazi P, Villaverde Ramiro Á, Tur Giménez L, Gurnari C, Bullinger L, Hernandez JM. Voso MT, et al. Among authors: haferlach t. Blood. 2024 Nov 6:blood.2024026186. doi: 10.1182/blood.2024026186. Online ahead of print. Blood. 2024. PMID: 39504485
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.
Komrokji RS, Lanino L, Ball S, Bewersdorf JP, Marchetti M, Maggioni G, Travaglino E, Al Ali NH, Fenaux P, Platzbecker U, Santini V, Diez-Campelo M, Singh A, Jain AG, Aguirre LE, Tinsley-Vance SM, Schwabkey ZI, Chan O, Xie Z, Brunner AM, Kuykendall AT, Bennett JM, Buckstein R, Bejar R, Carraway HE, DeZern AE, Griffiths EA, Halene S, Hasserjian RP, Lancet J, List AF, Loghavi S, Odenike O, Padron E, Patnaik MM, Roboz GJ, Stahl M, Sekeres MA, Steensma DP, Savona MR, Taylor J, Xu ML, Sweet K, Sallman DA, Nimer SD, Hourigan CS, Wei AH, Sauta E, D'Amico S, Asti G, Castellani G, Delleani M, Campagna A, Borate UM, Sanz G, Efficace F, Gore SD, Kim TK, Daver N, Garcia-Manero G, Rozman M, Orfao A, Wang SA, Foucar MK, Germing U, Haferlach T, Scheinberg P, Miyazaki Y, Iastrebner M, Kulasekararaj A, Cluzeau T, Kordasti S, van de Loosdrecht AA, Ades L, Zeidan AM, Della Porta MG; International Consortium on Myelodysplastic Syndromes. Komrokji RS, et al. Among authors: haferlach t. Lancet Haematol. 2024 Nov;11(11):e862-e872. doi: 10.1016/S2352-3026(24)00251-5. Epub 2024 Oct 9. Lancet Haematol. 2024. PMID: 39393368 Review.
UBA1 dysfunction in VEXAS and cancer.
Sakuma M, Haferlach T, Walter W. Sakuma M, et al. Among authors: haferlach t. Oncotarget. 2024 Sep 30;15:644-658. doi: 10.18632/oncotarget.28646. Oncotarget. 2024. PMID: 39347709 Free PMC article. Review.
732 results